Restera Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $12.8M

  • Investors
  • 11

Restera General Information

Description

Developer of an injectable neurostimulation device designed to deliver a novel, less invasive treatment for obstructive sleep apnea. The company offers a clinical-stage medical device with a micro-injectable neurostimulation approach, opening collapsed airways, enabling patients with sleep apnea to achieve peaceful and restorative sleep while reducing the risk of serious health complications.

Contact Information

Website
www.resterasleep.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3930 Freedom Circle
  • Suite 120
  • Santa Clara, CA 95054
  • United States
Primary Industry
Therapeutic Devices
Vertical(s)
Digital Health, HealthTech
Corporate Office
  • 3930 Freedom Circle
  • Suite 120
  • Santa Clara, CA 95054
  • United States

Restera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Restera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 21-Jul-2025 $12.8M Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2024 Completed Startup
2. Early Stage VC (Series A) 01-Apr-2023 $25M $29.4M Completed Startup
1. Seed Round 15-Oct-2021 $4.4M $4.4M Completed Startup
To view Restera’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Restera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Restera Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Aphelion Capital Venture Capital Minority
Forepont Capital Partners Venture Capital Minority
Seraph Group Venture Capital Minority
Bonit Capital Family Office Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Restera FAQs

  • When was Restera founded?

    Restera was founded in 2020.

  • Where is Restera headquartered?

    Restera is headquartered in Santa Clara, CA.

  • What is the size of Restera?

    Restera has 10 total employees.

  • What industry is Restera in?

    Restera’s primary industry is Therapeutic Devices.

  • Is Restera a private or public company?

    Restera is a Private company.

  • What is the current valuation of Restera?

    The current valuation of Restera is .

  • What is Restera’s current revenue?

    The current revenue for Restera is .

  • How much funding has Restera raised over time?

    Restera has raised $42.2M.

  • Who are Restera’s investors?

    MedTech Innovator, Aphelion Capital, Forepont Capital Partners, Seraph Group, and Bonit Capital are 5 of 11 investors who have invested in Restera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process